We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI Helps Interpret Ambiguous Mammography Results

By HospiMedica International staff writers
Posted on 13 Feb 2018
A new study shows that magnetic resonance imaging (MRI) is the best choice for clarifying ambiguous mammography tests.

Researchers at the Medical University of Vienna (MedUni; Austria) and Diagnostikum Graz (Austria) conducted a retrospective study of 302 consecutive women (mean age 50 years) who underwent 3T breast MRI as an additional workup to conventional and clinical mammography findings. More...
The aim of the study was to investigate diagnostic performance and incidental lesion yield when using MRI as a problem-solving tool. All images were read by experienced, board-certified radiologists, with the reference standard being histopathology or follow-up after two years.

The researchers also developed a multiparametric protocol, which allows the examination of up to four patients per hour. The results revealed 53 true-positive, 243 true-negative, 20 false-positive, and two false-negative breast MRI findings. In 16 (5.3%) of all patients, incidental MRI lesions were detected, 37.5% of which were found to be malignant. Breast composition and the imaging findings that had led to referral in the first place had no significant influence on the diagnostic performance of breast MRI. The study was published on January 2, 2018, in PLOS One.

"MRI clearly shows whether findings are benign or malignant. Not only was MRI able to definitively characterize ambiguous findings as either benign or malignant but, on top of this, we were able to detect additional, previously undiscovered, malignant tumors,” said lead author Claudio Spick, of MedUni Vienna. “MRI scans are therefore an ideal, non-invasive and equivalent alternative to painful breast biopsies; moreover, in around five percent of cases they identify previously undetected malignant tumors.”

While breast MRI provides a very high sensitivity and negative predictive value, particularly in non-calcified breast lesions, problem-solving definitions are not well defined, and the empirical evidence about specific indications, such as architectural distortions, is sparse.

Related Links:
Medical University of Vienna
Diagnostikum Graz


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Morcellator
TCM 3000 BL
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.